Skip to main content
Top
Published in: Annals of Hematology 10/2009

01-10-2009 | Original Article

Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men

Authors: Palle Pedersen, Nils Milman

Published in: Annals of Hematology | Issue 10/2009

Login to get access

Abstract

This study analysed the influence of extrinsic factors on the phenotypic expression of HFE gene variants in ethnic Danish men. A cohort of 6,020 men aged 30-53 years was screened for HFE C282Y, H63D and S65C variants. Serum iron, serum transferrin, transferrin saturation, and serum ferritin were analysed in 1,452 men and 1,294 men completed a questionnaire on factors, which could influence iron balance. The C282Y allele was present in 5.6%, H63D in 12.8% and S65C in 1.8% of the men. In the entire series, 3% had elevated iron status markers (transferrin saturation ≥50%, ferritin ≥300 μg/L). Self-reported liver disease had an elevating effect and peptic ulcer a lowering effect on iron status markers. Age increased the fraction of men with elevated ferritin from 8.3% at 32-38 years to 16.2% at 46-53 years of age (p = 0.002). Blood donation had a lowering effect on iron status markers (p = 0.0001). Alcohol consumption elevated serum iron and serum ferritin (p = 0.001). Meat consumption had an elevating effect (p = 0.02) and milk consumption a lowering effect (p = 0.03) on serum ferritin. There was no influence of vitamin-mineral tablets on iron status markers. In adjusted logistic regression analysis, the HFE genotype had the highest impact on iron status markers; high alcohol consumption was significantly associated with elevated transferrin saturation. High age and high alcohol consumption were significantly associated with elevated ferritin and high egg consumption and blood donation was significantly associated with normal ferritin levels. In conclusion, the expressivity of HFE variant phenotypes in Danish men was enhanced by alcohol and meat consumption and decreased by milk and egg consumption and blood donation.
Literature
1.
go back to reference Milman N, Pedersen P, Steig T, Byg K-E, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744PubMedCrossRef Milman N, Pedersen P, Steig T, Byg K-E, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744PubMedCrossRef
2.
go back to reference Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47PubMedCrossRef Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47PubMedCrossRef
3.
go back to reference Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment. Cambrigde University Press, Cambrigde, pp 15–41 ISBN 0 521 593808 Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment. Cambrigde University Press, Cambrigde, pp 15–41 ISBN 0 521 593808
4.
go back to reference Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830–836PubMed Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830–836PubMed
5.
go back to reference Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724PubMedCrossRef Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724PubMedCrossRef
6.
go back to reference McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L (1999) Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 107:30–37PubMedCrossRef McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L (1999) Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 107:30–37PubMedCrossRef
7.
go back to reference McLaren GD, McLaren CE, Adams PC, Barton JC, Reboussin DM, Gordeuk VR, Acton RT, Harris EL, Speechley MR, Sholinsky P, Dawkins FW, Snively BM, Vogt TM, Eckfeldt JH, for the Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators (2008) Clinical manifestations of hemochromatosis in HFE C282Y Homozygotes identified by screening. Can J Gastroenterol 22:923–930PubMed McLaren GD, McLaren CE, Adams PC, Barton JC, Reboussin DM, Gordeuk VR, Acton RT, Harris EL, Speechley MR, Sholinsky P, Dawkins FW, Snively BM, Vogt TM, Eckfeldt JH, for the Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators (2008) Clinical manifestations of hemochromatosis in HFE C282Y Homozygotes identified by screening. Can J Gastroenterol 22:923–930PubMed
8.
go back to reference Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL (2002) Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 29:41–47PubMedCrossRef Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL (2002) Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 29:41–47PubMedCrossRef
9.
go back to reference Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10, 500 blood donors. Br J Haematol 114:474–484PubMedCrossRef Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10, 500 blood donors. Br J Haematol 114:474–484PubMedCrossRef
10.
go back to reference Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218PubMedCrossRef Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218PubMedCrossRef
11.
12.
go back to reference Allen KJ, Gurrin LC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM (2008) Iron overload related disease in HFE hereditary hemochromatosis. N Engl J Med 358:221–230PubMedCrossRef Allen KJ, Gurrin LC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM (2008) Iron overload related disease in HFE hereditary hemochromatosis. N Engl J Med 358:221–230PubMedCrossRef
13.
go back to reference Elsass P, Pedersen P, Husum K, Milman N (2008) Assessment of the psychological effects of genetic screening of hereditary hemochromatosis. Ann Hematol 87:397–404PubMedCrossRef Elsass P, Pedersen P, Husum K, Milman N (2008) Assessment of the psychological effects of genetic screening of hereditary hemochromatosis. Ann Hematol 87:397–404PubMedCrossRef
14.
go back to reference Pedersen P, Melsen GV, Milman N (2008) Frequencies of the haemochromatosis (HFE) gene variants C828Y, H63D and S65C in 6, 020 ethnic Danish men. Ann Hematol 87:735–740PubMedCrossRef Pedersen P, Melsen GV, Milman N (2008) Frequencies of the haemochromatosis (HFE) gene variants C828Y, H63D and S65C in 6, 020 ethnic Danish men. Ann Hematol 87:735–740PubMedCrossRef
15.
go back to reference Milman N (1991) Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele. Eur J Haematol 47:292–298PubMed Milman N (1991) Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele. Eur J Haematol 47:292–298PubMed
16.
go back to reference Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRef Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRef
17.
go back to reference Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 77:13–19PubMedCrossRef Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 77:13–19PubMedCrossRef
18.
go back to reference Andersen RV, Tybjærg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG (2004) Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:2914–2919PubMedCrossRef Andersen RV, Tybjærg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG (2004) Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:2914–2919PubMedCrossRef
19.
go back to reference Milman N, Byg K-E, Ovesen L, Kirchhoff M, Jürgensen KS (2002) Iron status in Danish men 1984–94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 68:332–340PubMedCrossRef Milman N, Byg K-E, Ovesen L, Kirchhoff M, Jürgensen KS (2002) Iron status in Danish men 1984–94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 68:332–340PubMedCrossRef
20.
go back to reference Lyhne N, Christensen T, Groth MV, Fagt S, Biltoft-jensen A, Hartkoop H, et al. Danskernes Kostvaner 2000-2002. Hovedresultater (Danish Nutrition Habits 2000-2002. Main results) DFVF Publication no. 11. ISBN 87-988795-5-3. Silkeborg 2005 Lyhne N, Christensen T, Groth MV, Fagt S, Biltoft-jensen A, Hartkoop H, et al. Danskernes Kostvaner 2000-2002. Hovedresultater (Danish Nutrition Habits 2000-2002. Main results) DFVF Publication no. 11. ISBN 87-988795-5-3. Silkeborg 2005
21.
go back to reference Cook (2000) Hemochromatosis: effect of iron fortification of foods. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 535–543 Cook (2000) Hemochromatosis: effect of iron fortification of foods. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 535–543
22.
go back to reference Milman N, Kirchhoff M (1996) Relationship between serum ferritin, alcohol intake, and social status in 2235 Danish men and women. Ann Hematol 72:145–151PubMedCrossRef Milman N, Kirchhoff M (1996) Relationship between serum ferritin, alcohol intake, and social status in 2235 Danish men and women. Ann Hematol 72:145–151PubMedCrossRef
23.
go back to reference Baynes RD (2000) Interaction of alcohol, iron and hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis. Genetics, pathophysiology, diagnosis And treatment. Cambrigde University Press, Cambrigde, pp 468–474 ISBN 0 521 593808 Baynes RD (2000) Interaction of alcohol, iron and hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis. Genetics, pathophysiology, diagnosis And treatment. Cambrigde University Press, Cambrigde, pp 468–474 ISBN 0 521 593808
24.
go back to reference Moirand R, Lescoat G, Delamaire D, Lauvin L, Campion JP, Deugnier Y, Brissot P (1991) Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol Clin Exp Res 15:963–969PubMedCrossRef Moirand R, Lescoat G, Delamaire D, Lauvin L, Campion JP, Deugnier Y, Brissot P (1991) Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol Clin Exp Res 15:963–969PubMedCrossRef
25.
go back to reference Loreal O, Deugnier Y, Moirand R, Lauvin L, Guyader D, Jouanolle H, Turlin B, Lescoat G, Brissot P (1992) Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol 16:122–127PubMedCrossRef Loreal O, Deugnier Y, Moirand R, Lauvin L, Guyader D, Jouanolle H, Turlin B, Lescoat G, Brissot P (1992) Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol 16:122–127PubMedCrossRef
26.
go back to reference Brissot P. Clinical spectrum of hepatic disease in hemochromatosis. In Barton JC, Edwards CQ (eds). Hemochromatosis. Genetics, pathophysiology, diagnosis And treatment. Cambrigde. Cambrigde University Press ISBN 0 521 593808: p 250-257 Brissot P. Clinical spectrum of hepatic disease in hemochromatosis. In Barton JC, Edwards CQ (eds). Hemochromatosis. Genetics, pathophysiology, diagnosis And treatment. Cambrigde. Cambrigde University Press ISBN 0 521 593808: p 250-257
27.
go back to reference Milman N, Ovesen L, Byg K-E, Graudal N (1999) Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40–70 years. Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 78:393–400PubMedCrossRef Milman N, Ovesen L, Byg K-E, Graudal N (1999) Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40–70 years. Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 78:393–400PubMedCrossRef
28.
go back to reference Milman N, Søndergaard M (1984) Iron stores in male blood donors: evaluation by serum ferritin. Transfusion 24:464–468PubMedCrossRef Milman N, Søndergaard M (1984) Iron stores in male blood donors: evaluation by serum ferritin. Transfusion 24:464–468PubMedCrossRef
29.
go back to reference Milman N, Kirchhoff M (1991) The influence of blood donation on iron stores assessed by serum ferritin and haemoglobin in a population survey of 1433 Danish males. Eur J Haematol 47:134–149PubMed Milman N, Kirchhoff M (1991) The influence of blood donation on iron stores assessed by serum ferritin and haemoglobin in a population survey of 1433 Danish males. Eur J Haematol 47:134–149PubMed
30.
go back to reference Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW (1990) Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 74:525–530PubMedCrossRef Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW (1990) Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 74:525–530PubMedCrossRef
31.
go back to reference Bergström E, Hernell O, Lönnerdal B, Persson LA (1995) Sex differences in iron stores of adolescents: what is normal? J Pediatr Gastroenterol Nutr 20:215–224PubMed Bergström E, Hernell O, Lönnerdal B, Persson LA (1995) Sex differences in iron stores of adolescents: what is normal? J Pediatr Gastroenterol Nutr 20:215–224PubMed
32.
go back to reference Barton JC, Conrad ME, Parmley RT (1983) Calcium inhibition of inorganic iron absorption in rats. Gastroenterology 84:90–101PubMed Barton JC, Conrad ME, Parmley RT (1983) Calcium inhibition of inorganic iron absorption in rats. Gastroenterology 84:90–101PubMed
33.
go back to reference Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C (1998) Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 43:699–704PubMedCrossRef Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C (1998) Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 43:699–704PubMedCrossRef
34.
go back to reference Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L (1991) Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54:152–156PubMed Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L (1991) Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54:152–156PubMed
35.
go back to reference O’Brien KO, Zavaleta N, Caulfield LE, Wen J, Abrams SA (2000) Prenatal iron supplements impair zinc absorption in pregnant Peruvian women. J Nutr 130:2251–2255PubMed O’Brien KO, Zavaleta N, Caulfield LE, Wen J, Abrams SA (2000) Prenatal iron supplements impair zinc absorption in pregnant Peruvian women. J Nutr 130:2251–2255PubMed
36.
go back to reference Grønbæk KE, Milman N, Skødt V (1995) Preclinical hereditary hemochromatosis - is there an indication for preventive screening? Ugeskr Laeger 157:4249–4250PubMed Grønbæk KE, Milman N, Skødt V (1995) Preclinical hereditary hemochromatosis - is there an indication for preventive screening? Ugeskr Laeger 157:4249–4250PubMed
37.
go back to reference Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E (2000) The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 35:1301–1307PubMedCrossRef Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E (2000) The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 35:1301–1307PubMedCrossRef
38.
go back to reference Hennigar GR, Greene WB, Walker EM, de Saussure C (1979) Hemochromatosis caused by excessive vitamin iron intake. Am J Pathol 96:611–623PubMed Hennigar GR, Greene WB, Walker EM, de Saussure C (1979) Hemochromatosis caused by excessive vitamin iron intake. Am J Pathol 96:611–623PubMed
39.
go back to reference Perez RF, Amigo EA, Gonzalez CP (1998) Hemochromatosis presenting as acute liver failure after iron supplementation. N Engl J Med 339:269–270CrossRef Perez RF, Amigo EA, Gonzalez CP (1998) Hemochromatosis presenting as acute liver failure after iron supplementation. N Engl J Med 339:269–270CrossRef
40.
go back to reference Milman N, Rosenstock S, Andersen L, Jørgensen T, Bonnevie O (1998) Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiological survey comprising 2754 Danish adults. Gastroenterology 115:268–274PubMedCrossRef Milman N, Rosenstock S, Andersen L, Jørgensen T, Bonnevie O (1998) Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiological survey comprising 2754 Danish adults. Gastroenterology 115:268–274PubMedCrossRef
Metadata
Title
Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men
Authors
Palle Pedersen
Nils Milman
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 10/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0714-x

Other articles of this Issue 10/2009

Annals of Hematology 10/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.